Clinical Trial

A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia

Name: A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia — clinical trial record (NCT07016269)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The objective of this clinical trial is to evaluate the efficacy and safety of CnU capsule 500 mg administration in patients with biliary dyspepsia

Protocol Amendment History 2 changes

notable Primary completion pushed: 2026-06 -> 2027-11-10 2026-07-30

minor Completion pushed: 2026-06 -> 2028-06-13 2026-07-30

Trial Details

NCT Number	NCT07016269
Lead Sponsor	Myungmoon Pharma. Co. Ltd.
Conditions	Biliary Dyspepsia
Enrollment	358 participants
Start Date	2025-08-29
Primary Completion	2027-11-10 (estimated)
Study Completion	2028-06-13 (estimated)
Updated on ClinicalTrials.gov	2026-07-29